And, mammalian target of rapamycin (mTOR) gene and insulin-like growth factor 1 receptor (IGF1R) are direct target of miRNA-100 in bladder cancer, acute myelocytic leukemia, endometrioid endometrial carcinoma and so on [12, 16, 20, 32]. This evidence concerns the gene MTOR and endometrial endometrioid carcinoma.